Chronic Myeloid Leukemia (CML)
A Coveler, VG Oehler - Leukemia and Related Disorders: Integrated …, 2012 - Springer
Chronic myeloid leukemia (CML) is a relatively rare form of leukemia, comprising∼ 15% of
all leukemia cases. According to the National Cancer Institute's Surveillance Epidemiology …
all leukemia cases. According to the National Cancer Institute's Surveillance Epidemiology …
Response to imatinib mesylate in patients with early chronic phase chronic myeloid leukemia and derivative chromosome 9 deletion or clonal evolution
MU Shaikh, T Moatter, NN Syed… - Journal of Clinical & …, 2014 - ecommons.aku.edu
Objectives: The significance of clonal evolution and derivative chromosome 9 in
Philadelphia-positive CML is not fully characterized and studies have yielded conflicting …
Philadelphia-positive CML is not fully characterized and studies have yielded conflicting …
Ph: Not bad at all
F Guilhot - Blood, The Journal of the American Society of …, 2011 - ashpublications.org
23 JUNE 2011 I VOLUME 117, NUMBER 25 22 sequences. These deletions are seen more
frequently in cases of variant translocation (30%-40%). der9 deletions do not correlate with …
frequently in cases of variant translocation (30%-40%). der9 deletions do not correlate with …
Прогнозирование эффективности таргетной терапии на основании биологических характеристик хронического миелолейкоза
МС Фоминых - 2016 - elibrary.ru
Применение первого ингибитора тирозинкиназ–иматиниба в клинической практике в
течение последнего десятилетия позволило кардинально повысить выживаемость …
течение последнего десятилетия позволило кардинально повысить выживаемость …
[图书][B] Chronic Myeloid Leukemia
MJ Mauro - 2021 - Springer
Chronic myeloid leukemia (CML) has evolved, on the basis of seminal research and
transformative drug development, from a disease with a predictable short survival and …
transformative drug development, from a disease with a predictable short survival and …
[PDF][PDF] Chronic myeloid leukemia
SB de Patologia, SB de Pediatria… - Revista da Associação …, 2013 - core.ac.uk
Objectives To set parameters for clinical diagnosis, to evaluate severity, and to standardize
treatment, maintenance, and monitoring options for chronic myeloid leukemia (CML) …
treatment, maintenance, and monitoring options for chronic myeloid leukemia (CML) …
[HTML][HTML] population-based study
OV Lazareva, AG Turkina, EY Chelysheva… - old.bloodjournal.ru
Background. Much attention has been paid to molecule-genetic diagnostics of chronic
myeloid leukemia (CML) and its treatment using new highly effective methods of therapy …
myeloid leukemia (CML) and its treatment using new highly effective methods of therapy …
[HTML][HTML] clinical and hematological characteristics
OV Lazareva, AG Turkina, EY Chelysheva… - old.bloodjournal.ru
Background. Much attention has been paid to molecule-genetic diagnostics of chronic
myeloid leukemia (CML) and its treatment using new highly effective methods of therapy …
myeloid leukemia (CML) and its treatment using new highly effective methods of therapy …
[HTML][HTML] Fluorescence In situ hybridization signal patterns and intrachromosomal breakpoint cluster region-abelson murine leukemia viral oncogene homolog 1 …
KBK Bommannan, S Naseem, N Varma… - Journal of Applied …, 2019 - journals.lww.com
BACKGROUND: Cytogenetic evaluation is required till a complete cytogenetic remission is
achieved in chronic myelogenous leukemia (CML) patients on tyrosine kinase inhibitor (TKI) …
achieved in chronic myelogenous leukemia (CML) patients on tyrosine kinase inhibitor (TKI) …
Valutazione del management del paziente affetto da leucemia mieloide cronica nella pratica clinica dell'Azienda ULSS 2 marca trevigiana, distretto di Treviso …
A Bettiol - 2018 - research.unipd.it
Introduction Chronic myeloid leukemia (CML) is a myelodysplastic neoplasia accounting for
around 15% of all cases of leukemia in adults. CML treatment is mainly based on tyrosine …
around 15% of all cases of leukemia in adults. CML treatment is mainly based on tyrosine …